Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.
about
Tau Biology and Tau-Directed Therapies for Alzheimer's DiseaseIntranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration.Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.Microtubule Destabilization Paves the Way to Parkinson's Disease.Emerging Diagnostic and Therapeutic Strategies for Tauopathies.Tau Diagnostics and Clinical Studies.Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.A role for TENM1 mutations in congenital general anosmia.ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect.Repositioning Microtubule Stabilizing Drugs for Brain Disorders
P2860
Q28071398-8D445DF8-0048-4A49-870A-1FBED95E05ABQ38569775-FCF4ACB4-E6BE-4679-BD97-ABFEF1492E2CQ38636792-FA007E0F-DD5F-4665-83FE-89CB27AED639Q38730062-BA4E48C5-093C-4769-A588-61D24A00174CQ38741513-FD265608-96E3-47C1-B35A-FC068B73166BQ38766657-15CDE54A-FD43-450E-9242-2BD468837A90Q38984991-1467D610-269E-47A9-AC2D-C6AFE9BE5B72Q45870549-65F6EBAF-1809-4C35-9AF2-DB2E8EB5EAB6Q47870437-DEFB1268-3F66-4ABE-92D2-4C65AE80E049Q51762778-1C470313-677C-4108-BD78-A1ABD9359AE3Q52425135-43B13A0C-7E3A-49FA-A677-474C92FBD973Q55255816-0E35DCDA-4EDE-4D88-8A64-20D06EF0CB01Q58795487-1A9E69BE-9925-4ECA-8AF0-4EB5FD96CA67
P2860
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@ast
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@en
Intranasal NAP
@nl
type
label
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@ast
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@en
Intranasal NAP
@nl
prefLabel
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@ast
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@en
Intranasal NAP
@nl
P2093
P2860
P356
P1476
Intranasal NAP (davunetide) de ...... ce overexpressing α-synuclein.
@en
P2093
Alistair J Stewart
Bruce H Morimoto
Chunni Zhu
Franziska Richter
Iddo Magen
Illana Gozes
Regina Ostritsky
Sheila M Fleming
Vincent Lemesre
P2860
P304
P356
10.1002/PRP2.65
P577
2014-08-06T00:00:00Z